熱門資訊> 正文

Atea Pharmaceuticals第一季度裁员约25%

2025-03-27 02:09

Atea Pharmaceuticals(AVIR) 0

Atea Pharmaceuticals (NASDAQ:AVIR) announced on Wednesday an about 25% reduction in the workforce during the first quarter.
The layoffs are expected to result in cost savings of ~$15M through 2027.
Shares were trading 0.78% down as of 1:59 PM ET at $3.18.

More on Atea Pharmaceuticals

Atea Pharmaceuticals, Inc. (AVIR) Q4 2024 Earnings Call Transcript
Atea Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation
Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
Historical earnings data for Atea Pharmaceuticals
Financial information for Atea Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。